Refractory Chronic Cough Improvement Via NAL ER (RIVER)
Study sponsor: Trevi Therapeutics
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2025-01-06Actual
Enrollment · participants66Actual
Source updated2026-03-30Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.